GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Hybrid repellant-antimicrobial gemini coatings for prevention of catheter-associated bloodstream infections

$273,485
Kollbe Ahn · Acatechol, Inc. · R43 · FY2023 · AI

Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis

$273,458
Edward G Maliski · Oak Therapeutics, Inc. · R43 · FY2023 · AI

PepSAVI-MS for discovery of novel botanical antimicrobial peptides

$273,375
Leslie M. Hicks · Univ Of North Carolina Chapel Hill · R01 · FY2018 · GM

COMPUTATIONAL INSIGHTS INTO BACTERIAL RESISTANCE: ANTIBIOTICS

$273,230
University Of California San Francisco · P41 · FY2001 · RR

Use of host derived lipoate by Listeria monocytogenes

$273,223
Mary O'Riordan · University Of Michigan At Ann Arbor · R01 · FY2008 · AI

**AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** WHILE FRESH PRODUCE IS WELL-RECOGNIZED AS A MAJOR SOURCE OF ESSENTIAL NUTRIENTS FOR HEALTH AND WELLBEING, THE RAPIDLY INCREASED CONSUMPTION IS NOT ACCOMPANIED BY TECHNOLOGICAL ADVANCES TO MITIGATE THE GROWING BURDEN OF MICROBIAL CONTAMINATION. AS A RESULT, THIS TREND HAS INEVITABLY LED TO A GREATER NUMBER OF ILLNESSES AND DEATHS ASSOCIATED WITH FOODBORNE OUTBREAKS DUE TO CONTAMINATED FRESH PRODUCE. DUE TO HIGH NUTRIENT CONTENT, BACTERIA REMAIN ATTACHED TO THE IRREGULAR SURFACE OF FRESH PRODUCE AND SUBSEQUENTLY PROGRESS TO FORM BIOFILMS COMPRISING OF CONSORTIA OF BACTERIA LODGED IN A 3D EXTRACELLULAR MATRIX, OFFERING PROTECTION AGAINST EXTERNAL STRESSES AND BECOMING RESISTANT TO CLEANING AND DISINFECTION THAN PLANKTONIC CELLS. UNFORTUNATELY, CURRENT MICROBIAL CONTROL STRATEGIES, INCLUDING OZONE, CHLORINE, AND ORGANIC ACID, ARE UNABLE TO EFFICIENTLY ERADICATE HAZARDOUS MICROORGANISMS WITHOUT AFFECTING FOOD QUALITY, NOT TO MENTION THE SIDE EFFECTS FROM DISINFECTION BY-PRODUCTS. IT IS OF UTMOST IMPORTANCE TO DEVELOP NEW MITIGATION STRATEGY TO EFFICIENTLY AND SAFELY REMOVE MICROBIAL BIOFILM AS PART OF THE POSTHARVEST PRACTICES FOR FRESH PRODUCE. THE RAPID GROWTH OF KNOWLEDGE IN SCIENCE AND ENGINEERING HAS SPURRED SIGNIFICANT INTEREST IN DEVELOPING NANOTECHNOLOGY-ENABLED APPROACHES TO ENSURE FOOD SAFETY AND QUALITY. FOOD BIOPOLYMERS WITH NATURAL NANOSTRUCTURES ARE PROMISING CANDIDATES FOR THE ENCAPSULATION OF ANTIMICROBIALS. MEANWHILE, PHYTOCHEMICALS SUCH AS ESSENTIAL OILS (EOS) HAVE GAINED INCREASING ATTENTION FOR THEIR POTENT ANTIMICROBIAL EFFECTS AGAINST FOODBORNE PATHOGENIC MICROORGANISMS AND HAVE BEEN WIDELY APPLIED AS NATURAL PRESERVATIVES IN THE FOOD INDUSTRY.THE MAJOR HURDLE IN THE DEVELOPMENT OF NANOMATERIALS IS TO FIND NATURAL AND SAFE FOR FOOD APPLICATIONS. FOOD BIOPOLYMERS (INCLUDING CARBOHYDRATES AND PROTEINS) WITH NATURALLY OCCURRING NANOSTRUCTURES ARE THE IDEAL CANDIDATES AS SUCH. DISCOVERED FROM THE ENDOSPERM OF MUTANT GRAINS, PHYTOGLYCOGEN (PG) IS A NATURALLY OCCURRING STARCH-LIKE CARBOHYDRATE WITH HIGH MOLECULAR WEIGHT BUT THE NANOSCALE GRANULAR STRUCTURE.DUE TO THE DEFICIENCY OF DEBRANCHING ENZYME DURING BIOSYNTHESIS, THE AVERAGE CHAIN LENGTH IN PG IS 11-12 GLUCOSE UNITS WITH HIGH BRANCHING DENSITY, THUS EXISTING AS A DENDRITIC NANOSTRUCTURE. SUCH UNIQUE STRUCTURE MAKES IT AN IDEAL CARRIER FOR BIOACTIVE COMPOUNDS. IN THIS RESEARCH, WE ARE INSPIRED BY NATURAL DENDRITIC NANOSTRUCTURES FROM PGTO DEVELOP NOVEL NANOPARTICLES (NPS) FOR CO-DELIVERY OF SYNERGISTIC PHYTOCHEMICALS AS A HIGHLY EFFICIENT AND SAFE MITIGATION STRATEGY TO CONTROL MICROBIAL CONTAMINATION IN FRESH PRODUCE BY WASHING TREATMENT.EUGENOL AND CINNAMALDEHYDE ARE TWO PHYTOCHEMICALS WELL KNOWN FOR WIDE-SPECTRUM AND SYNERGISTIC ANTIMICROBIAL ACTIVITIES, BUT THE PRACTICAL APPLICATIONS ARE LIMITED BY THEIR POOR WATER SOLUBILITY. WE HYPOTHESIZE THAT EUGENOL AND CINNAMALDEHYDE CAN BE LOADED TO PG-BASED NANOPARTICLES VIA AN EASY AND FACILE TECHNIQUE THAT IS HIGHLY PRACTICAL AND APPLICABLE FOR SCALE-UP PRODUCTION.THE NANOPARTICLES SOLUTION CAN BE APPLIED AS WASHING WATER TO EFFICIENTLY IMPROVE THE MICROBIAL SAFETY OF FRESH PRODUCE. STRAWBERRY, CUCUMBER, LETTUCE, AND CANTALOUPE WILL BE TESTED IN THIS PROJECT UNDER TWO SITUATIONS, INCLUDING PREVENTION OF MICROBIAL GROWTH DURING POSTHARVEST TREATMENT AND ERADICATION OF BACTERIA FROM ALREADY CONTAMINATED PRODUCTS.THE SCIENTIFIC FINDINGS OF THIS STUDY WILL DIRECTLY CONTRIBUTE TO THE U.S. AGRICULTURE BY DEVELOPING ALTERNATIVE DISINFECTANTS AS NOVEL MITIGATION STRATEGIES TO IMPROVE MICROBIAL SAFETY AND QUALITY OF FRESH PRODUCE. PROGRAM AREA PRIORITY, FOOD SAFETY AND DEFENSE, GAINING FUNDAMENTAL AND APPLIED KNOWLEDGE TO DEVELOP AND VALIDATE NOVEL STRATEGIES FOR THE EFFECTIVE CONTROL OF FOODBORNE PATHOGENS, WILL BE ADDRESSED.

$273,000
University Of Connecticut · · FY2022 · National Institute of Food and Agriculture

Optimizing Lead Therapeutic Compounds Against Infectious Diseases

$272,974
Eva Garland · Agile Sciences, Inc. · N01 · FY2016 · AI

Dynamics of Antimicrobial Peptide Interactions with Bacterial Membranes

$272,928
James C. Weisshaar · University Of Wisconsin-Madison · R01 · FY2015 · GM

Mechanisms of Macrolide Resistance in Mycobacteria

$272,869
Kevin A Nash · Children'S Hospital Of Los Angeles · R01 · FY2010 · AI

Oral Chlorhexidine effect on ICU mortality and ventilator-associated pneumonia

$272,810
Catherine J Binkley · University Of Louisville · R21 · FY2007 · DE

MECHANISMS OF VIRULENCE GENE REGULATION IN S. AUREUS

$272,803
U.S. Agriculture Research Service-Midsou · R01 · FY2002 · AI

Vibrio fischeri as a model of bacterial colonization

$272,750
University Of Wisconsin Madison · R01 · FY2004 · AI

Vibrio fischeri as a model of bacterial colonization

$272,750
University Of Wisconsin Madison · R01 · FY2005 · AI

Solid-state NMR of antimicrobial and cationic membrane peptides

$272,733
Mei Hong · Iowa State University · R01 · FY2011 · GM

The nasopharyngeal microbiota of African children and lower respiratory tract infection

$272,629
Mark Patrick Nicol · University Of Cape Town · U54 · FY2018 · HG

VTEU: Noninferiority Trial to Inform Treatment of Lower Respiratory Tract Infections (LRTI)

$272,626
Hana El Sahly · Baylor College Of Medicine · N01 · FY2020 · AI

Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections

$272,492
Michael William Climo · Richmond Institute For Veterans Research · U01 · FY2007 · CI

GCR: Collaborative Research: Plasma-Biofilm Interactions at the Intersection of Physics, Chemistry, Biology and Engineering

$272,450
Mark J Kushner · Regents Of The University Of Michigan - Ann Arbor · · FY2020 · MPS

Mechanism of Enzymes Mediating Resistance in Pseudomonas

$272,408
Marcelo Carlos Sousa · University Of Colorado · R01 · FY2008 · AI

Infectious Disease Training in Clinical Investigation

$272,401
University Of Minnesota Twin Cities · T32 · FY2005 · AI

Rapid lateral flow-based antibiotic susceptibility testing for urinary tract infections

$272,184
Emily S Melzer · Latde Diagnostics Corp. · R43 · FY2025 · AI

Metallobiochemistry of innate immunity and bacterial physiology

$272,173
Elizabeth M Nolan · Massachusetts Institute Of Technology · R01 · FY2019 · GM

INNATE HOST DEFENSE IN THE HUMAN VAGINA

$272,136
University Of California Los Angeles · R01 · FY2003 · AI

Study of Mechanisms Leading to Multidrug-Resistant K. pneumoniae and A. baumannii

$272,125
John M Quale · Suny Downstate Medical Center · R01 · FY2007 · AI

Chemical biology of type IV secretion systems

$271,953
Carrie Shaffer · University Of Kentucky · P20 · FY2021 · GM